Cargando…
Hepatitis C Virus Antigenic Convergence
Vaccine development against hepatitis C virus (HCV) is hindered by poor understanding of factors defining cross-immunoreactivity among heterogeneous epitopes. Using synthetic peptides and mouse immunization as a model, we conducted a quantitative analysis of cross-immunoreactivity among variants of...
Autores principales: | Campo, David S., Dimitrova, Zoya, Yokosawa, Jonny, Hoang, Duc, Perez, Nestor O., Ramachandran, Sumathi, Khudyakov, Yury |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279735/ https://www.ncbi.nlm.nih.gov/pubmed/22355779 http://dx.doi.org/10.1038/srep00267 |
Ejemplares similares
-
Convergence and coevolution of Hepatitis B virus drug resistance
por: Thai, Hong, et al.
Publicado: (2012) -
Transmissibility of intra-host hepatitis C virus variants
por: Campo, David S., et al.
Publicado: (2017) -
Increased Mitochondrial Genetic Diversity in Persons Infected With Hepatitis C Virus
por: Campo, David S., et al.
Publicado: (2016) -
Changing Molecular Epidemiology of Hepatitis A Virus Infection, United States, 1996–2019
por: Ramachandran, Sumathi, et al.
Publicado: (2021) -
Efficient error correction for next-generation sequencing of viral amplicons
por: Skums, Pavel, et al.
Publicado: (2012)